Durogesic DTrans opioid tolerance

The prescribing information for Durogesic DTrans (fentanyl patch) has been updated to include details regarding initial dose selection and use in opioid-naïve patients.

Durogesic DTrans should only be used in patients who have demonstrated opioid tolerance.

The initial dose should be based on the patient’s opioid history, including the degree of opioid tolerance, if any, as well as on the current general condition and medical status of the patient.

In strong opioid-naïve patients, treatment should be initiated with the 25 microgram per hour patch.

Clinical experience is limited in opioid-naïve patients. If therapy is considered appropriate in these patients, titrate with low doses of short-acting opioids before converting to Durogesic DTrans 25 microgram per hour.

View Durogesic DTrans drug record

Further information: Janssen-Cilag Ltd

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Urgent prescribing updates
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases